The Evolving Landscape of International Drug Policy Reform and Cannabis Use in California

The course objects of this activity are listed to the left. As you proceed through the activity, your progress will be indicated.

 

Learning Objectives

As a result of participating in this lecture, learners will have a working knowledge of the following topics:

  1. Cannabis Initiatives, including medicalization, the pharmacotherapeutic future of cannabinoid agonists and antagonists, and the unique vulnerability of youth;
  2. International stance on the War on Drugs;
  3. “Soft vs. Hard” drugs, including the gateway concept and assessing harms to self vs. harms to society caused by various drugs of abuse;
  4. Sentencing Reforms
Course summary
Available credit: 
  • 0.50 AAPA
  • 0.50 AMA Category 1
  • 0.50 CAADAC
Course opens: 
09/15/2014
Course expires: 
08/31/2017
Cost:
$0.00
Part of: 
Addiction Medicine Review Course 2014
Rating: 
0

Peter Banys, MD, MSc
Dr. Banys has been living and working in Hanoi as a Technical Advisor for an international NGO, assisting Vietnam in its scale-up of MMT as a response to an HIV epidemic. He is also working with Vietnam’s National Institute of Mental Health (NIMH) to expand advanced training. He is a Clinical Professor of Psychiatry at UCSF.  He has served on a federal advisory board for methadone treatment and was a co-author of a California Department of Alcohol & Drugs Report on Co-Occurring Disorders. He is a member of Gavin Newsom's Blue Ribbon advisory panel on marijuana policy reform in the State of California.  He is the Past-President of CSAM and a past-member of the Executive Board of ASAM. 

Dr. Banys has no relevant financial relationships to disclose.

Available Credit

  • 0.50 AAPA
  • 0.50 AMA Category 1
  • 0.50 CAADAC

Price

Cost:
$0.00
Please login or register to take this course.